Meclizine and Copaxone drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among 231 people who take Meclizine and Copaxone. Common interactions include musculoskeletal stiffness among females, and drug ineffective among males.
The phase IV clinical study analyzes what interactions people who take Meclizine and Copaxone have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
231 people who take Meclizine and Copaxone together, and have interactions are studied.
What is Meclizine?
Meclizine has active ingredients of meclizine hydrochloride. It is used in dizziness. Currently, eHealthMe is studying from 21,978 Meclizine users.
What is Copaxone?
Copaxone has active ingredients of glatiramer acetate. It is used in multiple sclerosis. Currently, eHealthMe is studying from 55,934 Copaxone users.
Number of Meclizine and Copaxone reports submitted per year:
Meclizine and Copaxone drug interactions by gender *:
Meclizine and Copaxone drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Meclizine and Copaxone?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .
- Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
Drug side effects by duration, gender and age:
Common Meclizine drug interactions:
- Meclizine and Aspirin: 4,523 reports
- Meclizine and Gabapentin: 3,325 reports
- Meclizine and Omeprazole: 3,210 reports
- Meclizine and Lisinopril: 2,718 reports
- Meclizine and Vitamin d: 2,552 reports
- Meclizine and Prednisone: 2,387 reports
- Meclizine and Furosemide: 2,325 reports
- Meclizine and Tramadol: 2,189 reports
- Meclizine and Nexium: 2,049 reports
- Meclizine and Metformin: 2,025 reports
Browse interactions between Meclizine and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Copaxone drug interactions:
- Copaxone and Ampyra: 5,740 reports
- Copaxone and Baclofen: 3,358 reports
- Copaxone and Vitamin d: 3,303 reports
- Copaxone and Gabapentin: 2,335 reports
- Copaxone and Avonex: 2,238 reports
- Copaxone and Tysabri: 1,569 reports
- Copaxone and Tecfidera: 1,486 reports
- Copaxone and Aspirin: 1,179 reports
- Copaxone and Vitamin b12: 1,096 reports
- Copaxone and Gilenya: 1,048 reports
Browse interactions between Copaxone and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on meclizine hydrochloride and glatiramer acetate (the active ingredients of Meclizine and Copaxone, respectively), and Meclizine and Copaxone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Meclizine and Copaxone.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Calcium and Zinecard drug interaction - 13 seconds ago
- Plavix and Gastrointestinal Angiodysplasia Haemorrhagic - 14 seconds ago
- Alupent and Arrhythmias - 19 seconds ago
- Tamoxifen Citrate and Squamous Cell Carcinoma Of Skin - 21 seconds ago
- Vyvanse and Blood Thyroid Stimulating Hormone Decreased - 23 seconds ago
- Mycamine and Maxipime drug interaction - 27 seconds ago
- Januvia and Genital Abscess - 27 seconds ago
- Crestor and Thrombophlebitis - 28 seconds ago
- Tramadol Hydrochloride and Linaclotide drug interaction - 31 seconds ago
- Chromium and Tenex drug interaction - 46 seconds ago